Out of more than 250 abstracts submitted at its annual meeting in Boston, SCCT named one winner and two runners-up. 

Anjali Owens, MD, discussed the past, present and future of hypertrophic cardiomyopathy care in the United States. "What we are aiming to do is develop a minimum standard for assessments of patients with HCM so they are getting properly diagnosed and managed," she explained. 

The American Hospital Association is sounding the alarm over evidently widespread acceptance of 0% operating margins—or even negative margins—as a sort of “new normal” for U.S. hospitals and health systems.  

The Hypertrophic Cardiomyopathy Association (HCMA) has helped guide and advance HCM care not only for patients, but also for hospitals and physicians. 

Several key trends at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography were outlined by society President Ed Nicol, MD, including AI, reimbursement issue, business management discussions, and a growing interest in cardiac CT leading to record attendance this year.

AI to help interpret cardiac CT was shown to reduce exam read times to improve workflow efficiency, and improve patient diagnostics with additional information on soft plaques. Data was presented in three HeartFlow AI technology studies at SCCT 2023.

The FDA approved UltraSight's AI to show ultrasound users how to perform a diagnostic quality cardiac ultrasound exam at the point of care in multiple settings.

The college issued a detailed breakdown of the 2024 MPFS, offering insight into the “complex” formula for how much the specialty stands to lose.